Treatment for SARS-CoV-2 and other coronaviruses
US11419917B2 · kind B2 · utility
0Cited by
6References
5Claims
0Family size
Inventor
Key dates
| Filing date | Apr 2, 2021 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Apr 2, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a corona virus infection in a human includes administering to the human an effective amount of at least one a natriuretic peptide (NP) and a neprilysin inhibitor (NI). A pharmaceutical composition for the treatment of corona virus in a human includes one of a recombinant natriuretic peptide (rNP) and a chimeric natriuretic peptide D (CD-NP) and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.